What is International Biotechnology Trust Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Feb. 2024,
International Biotechnology Trust paid£6.75 Mil more to buy back shares than it received from issuing new shares.
It received£28.31 Mil from issuing more debt.
It paid£0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent£5.39 Mil paying cash dividends to shareholders.
It received£0.00 Mil on other financial activities.
In all, International Biotechnology Trustearned£16.17 Mil on financial activities for the
six
months ended in Feb. 2024.
International Biotechnology Trust Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
International Biotechnology Trust Cash Flow from Financing Chart
International Biotechnology Trust Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Feb. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £1.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust (LSE:IBT) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
International Biotechnology Trust's issuance of stock for the
six
months ended in Feb. 2024 was £0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
International Biotechnology Trust's repurchase of stock for the
six
months ended in Feb. 2024 was £-6.75 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
International Biotechnology Trust's net issuance of debt for the
six
months ended in Feb. 2024 was £28.31 Mil.
International Biotechnology Trust received£28.31 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
International Biotechnology Trust's net issuance of preferred for the
six
months ended in Feb. 2024 was £0.00 Mil.
International Biotechnology Trust paid£0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
International Biotechnology Trust's cash flow for dividends for the
six
months ended in Feb. 2024 was £-5.39 Mil.
International Biotechnology Trust spent£5.39 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
International Biotechnology Trust's other financing for the
six
months ended in Feb. 2024 was £0.00 Mil.
International Biotechnology Trust received£0.00 Mil on other financial activities.
International Biotechnology Trust Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of International Biotechnology Trust's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
International Biotechnology Trust (LSE:IBT) Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
International Biotechnology Trust (LSE:IBT) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:IBT has been successfully added to your 